JENNIFER PARIS: Open Payments
NPI 1750513149 · BURLESON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,983 in 78 payments from 36 companies in 2025. Trend: 2023 $1,371 · 2024 $1,905 · 2025 $1,983
Food & beverage: $1,859Education: $85Entertainment: $39
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 9 | $226 |
| AstraZeneca Pharmaceuticals LP | 6 | $204 |
| Incyte Corporation | 3 | $172 |
| Janssen Biotech, Inc. | 9 | $145 |
| Gilead Sciences, Inc. | 6 | $123 |
| Regeneron Healthcare Solutions, Inc. | 3 | $116 |
| SEAGEN INC. | 1 | $85 |
| Celgene Corporation | 3 | $83 |
| Merck Sharp & Dohme LLC | 3 | $74 |
| Caris MPI, Inc. | 2 | $54 |
Products named: Enhertu, MONJUVI, DATROWAY, Trodelvy, LIBTAYO, KEYTRUDA, OPDUALAG, MI CANCER SEEK.
Industry payments across TX — which companies pay providers there.
